Overexpression of Cks1 increases the radiotherapy resistanceof esophageal squamous cell carcinoma

Journal of Radiation Research

Volumn 53, Issue 1, 2012, Pages 72-78

  Wang, Xiao Chun ^a   Tian, Li Li ^b   Tian, Jin ^c   Li, Deguan ^a   Wang, Yueying ^a   Wu, Hongying ^a   Zheng, Hang ^a   Meng, Ai Min ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Shandong Province Institute of Cancer Prevention and Treatment   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; PROTEINS; TUMORS;

CARCINOMA PATIENTS; CARCINOMA TISSUES; COFACTORS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NEGATIVE CORRELATION; OVEREXPRESSIONS; POSITIVE LYMPH NODES; UBIQUITINATION;

RADIOTHERAPY;

EID: 84863294060     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.11090     Document Type: Article

References (15)

1. Berger B and Belka C (2009) Evidence-based radiation oncology: oesophagus. Radiother Oncol 92: 276-290.
2. Jemal A, et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96. (Pubitemid 351521864)
3. Borghesi S, Hawkins MA and Tait D (2008) Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer. Clin Oncol (R Coll Radiol) 20: 221-226.
4. Minsky BD, et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20: 1167-1174. (Pubitemid 34177421)
5. Spruck C, et al (2001) A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 7: 639-650. (Pubitemid 32706355)
6. Ganoth D, et al (2001) The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 3: 321-324. (Pubitemid 32201330)
7. Shapira M, et al (2005) The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 103: 1336-1346. (Pubitemid 40410727)
8. Sitry D, et al (2002) Three different binding sites of Cks1 are required for p27-ubiquitin ligation. J Biol Chem 277: 42233-42240. (Pubitemid 35257543)
9. Wang XC, et al (2009) Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma. Mol Cancer Res 7: 12-22.
10. Masuda TA, et al (2003) Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Clin Cancer Res 9: 5693-5698.
11. Inui N, et al (2003) High expression of Cks1 in human non-small cell lung carcinomas. Biochem Biophys Res Commun 303: 978-984. (Pubitemid 36384952)
12. Lan Y, et al (2008) Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer 123: 543-551. (Pubitemid 351898411)
13. Slotky M, et al (2005) The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res 7: R737-R744.
14. Liberal V, et al (2011) Breast Cancer Special Feature: Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins. Proc Natl Acad Sci USA. doi: 10.1073/ pnas.1102434108.
15. Tsai YS, et al (2005) RNA silencing of Cks1 induced G2/M arrest and apoptosis in human lung cancer cells. IUBMB Life 57: 583-589.